Use of several immunological markers to model the probability of active tuberculosis

Diagnostic Microbiology and Infectious Disease

Volumn 86, Issue 2, 2016, Pages 169-171

  Petruccioli, Elisa ^a   Navarra, Assunta ^a   Petrone, Linda ^a   Vanini, Valentina ^a   Cuzzi, Gilda ^a   Gualano, Gina ^a   Palmieri, Fabrizio ^a   Girardi, Enrico ^a   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Biomarkers; CD27; Diagnosis; Latent infection; Phenotype; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; CD27 ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL MARKER; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CD27 MFI RATIO; CD27+ IFNGAMMA+ CD4+ T LYMPHOCYTE; CD27- IFNGAMMA+ CD4+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD45RA- CD27+ IFNGAMMA+ CD4+ T LYMPHOCYTE; CD45RA- CD27- IFNGAMMA+ CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; LATENT TUBERCULOSIS; LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; TNFALPHA+ IFNGAMMA+ CD4+ T LYMPHOCYTE; TUBERCULOSIS; CHEMISTRY; EVALUATION STUDY; FLOW CYTOMETRY; IMMUNOLOGY; MYCOBACTERIUM; PROCEDURES;

ANTIGENS, CD27; BIOMARKERS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84989899295     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.06.007     Document Type: Article

References (17)

1. Adekambi, T., Ibegbu, C.C., Cagle, S., Kalokhe, A.S., Wang, Y.F., Hu, Y., et al. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest 125:5 (2015), 1827–1838.
2. Day, C.L., Abrahams, D.A., Lerumo, L., Janse van Rensburg, E., Stone, L., O'rie, T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 187:5 (2011), 2222–2232.
3. Goletti, D., Sanduzzi, A., Delogu, G., Performance of the tuberculin skin test andinterferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl. 91 (2014), 24–31, 10.3899/jrheum.140099.
4. Harari, A., Rozot, V., Enders, F.B., Perreau, M., Stalder, J.M., Nicod, L.P., et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17:3 (2011), 372–376.
5. Lawn, S.D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B.J., et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13:4 (2013), 349–361.
6. Lonnroth, K., Migliori, G.B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45:4 (2015), 928–952.
7. Migliori, G.B., Hopewell, P.C., Blasi, F., Spanevello, A., Raviglione, M.C., Improving the TB case management: The International Standards for Tuberculosis Care. Eur Respir J 28:4 (2006), 687–690.
8. Nikitina, I.Y., Kondratuk, N.A., Kosmiadi, G.A., Amansahedov, R.B., Vasilyeva, I.A., Ganusov, V.V., et al. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans. PLoS One, 7(8), 2012, e43733.
9. Petruccioli, E., Petrone, L., Vanini, V., Cuzzi, G., Navarra, A., Gualano, G., et al. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. J Infect 71:5 (2015), 526–533.
10. Petruccioli, E., Petrone, L., Vanini, V., Sampaolesi, A., Gualano, G., Girardi, E., et al. IFNgamma/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 66:6 (2013), 475–486.
11. Pollock, K.M., Whitworth, H.S., Montamat-Sicotte, D.J., Grass, L., Cooke, G.S., Kapembwa, M.S., et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis 208:6 (2013), 952–968.
12. Portevin, D., Moukambi, F., Clowes, P., Bauer, A., Chachage, M., Ntinginya, N.E., et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 14:10 (2014), 931–938.
13. Richards, R.J., Hammitt, J.K., Tsevat, J., Finding the optimal multiple-test strategy using a method analogous to logistic regression: the diagnosis of hepatolenticular degeneration (Wilson's disease). Med Decis Making 16:4 (1996), 367–375.
14. Rozot, V., Patrizia, A., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., et al. Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis 60:3 (2015), 432–437.
15. Rozot, V., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., Perreau, M., et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 43:6 (2013), 1568–1577.
16. Schuetz, A., Haule, A., Reither, K., Ngwenyama, N., Rachow, A., Meyerhans, A., et al. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One, 6(11), 2011, e27284.
17. WHO, Global Tuberculosis report. http://www.who.int/tb/publications/global_report/en/, 2015.